spago cancer therapy-arkiv - BioStock

Spago_radiopharma_commercial_opportunity

Spago Nanomedical’s CEO: “huge commercial opportunities are unfolding”

27 March, 2024

Spago Nanomedical_2024 Momentum

2023 springboard for Spago’s radionuclide cancer therapy

9 February, 2024

Spago’s phase I/IIa cancer trial progressing steadily

Spago’s phase I/IIa cancer trial progressing steadily

15 January, 2024

Spago_TumoradPhase1_FirstPatient

First patient dosed in Spago’s phase I/IIa trial

14 December, 2023